Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients.

Díaz-Pedroche, Carmen; Lumbreras, Carlos; San Juan, Rafael; Folgueira, Dolores; Andrés, Amado; Delgado, Juan; Meneu, Juan Carlos; Morales, José María; Moreno-Elola, Almudena; Hernando, Susana; Moreno-González, Enrique; Aguado, José María

Díaz-Pedroche, Carmen; Lumbreras, Carlos; San Juan, Rafael; Folgueira, Dolores; Andrés, Amado; Delgado, Juan; Meneu, Juan Carlos; Morales, José María; Moreno-Elola, Almudena; Hernando, Susana; Moreno-González, Enrique; Aguado, José María.

Affiliation

Díaz-Pedroche C; Infectious Diseases Unit, Hospital Universitario Doce de Octubre, Universidad Complutense, Madrid, Spain.

Transplantation ; 82(1): 30-5, 2006 Jul 15.

Article in En | MEDLINE | ID: mdl-16861938

Subject(s)

Antiviral Agents/therapeutic use; Cytomegalovirus Infections/prevention & control; Ganciclovir/analogs & derivatives; Organ Transplantation; Adolescent; Adult; Antigens, Viral/blood; Antiviral Agents/adverse effects; Child; Cytomegalovirus/immunology; Female; Ganciclovir/adverse effects; Ganciclovir/therapeutic use; Humans; Male; Middle Aged; Valganciclovir

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ganciclovir / Organ Transplantation / Cytomegalovirus Infections Type of study: Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 2006 Type: Article Affiliation country: Spain

Search on Google

XML

PubMed Links